Adiponectin, Cardiovascular Function, and Hypertension

Wang, Zhao V.; Scherer, Philipp E.

doi:10.1161/hypertensionaha.107.099424

Cited by 247Adipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and AdiposityBlood Pressure and Hypertension Studies

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Adiponectin, Cardiovascular Function, and Hypertension

Open access

Wang, Zhao V., Scherer, Philipp E.·2008·Hypertension

DOI 10.1161/hypertensionaha.107.099424

Open this paper in CoChat — free account Open PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/hypertensionaha.107.099424

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Plasma adiponectin concentration is decreased in patients with obesity, especially those with excess visceral fat, and this downregulation is associated with insulin resistance, impaired glucose metabolism, decreased fatty acid metabolism, and ectopic fat accumulation.
“Plasma adiponectin concentration is decreased in patients with obesity, especially those with excess visceral fat, and this downregulation is associated with insulin resistance, impaired glucose metabolism, decreased fatty acid metabolism and ectopic fat accumulation114,115.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [115]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prevalence of Overweight and Obesity in the United States, 1999-2004
Ogden, C. L., Carroll, M. D., Curtin, L. R., McDowell, M. A., Tabak, C. J., & Flegal, K. M. (2006) · JAMA · doi:10.1001/jama.295.13.1549 · Cited by 8,720
Global burden of hypertension: analysis of worldwide data
Kearney, P. M., Whelton, M., Reynolds, K., Muntner, P., Whelton, P. K., & He, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17741-1 · Cited by 8,698
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508
Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol
Dahlöf, B., Devereux, R. B., Kjeldsen, S. E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08089-3 · Cited by 5,407
Prevalence of Overweight and Obesity in the United States
Crespo, C. J., & Smit, E. (2003) · Human Kinetics eBooks · doi:10.5040/9781718206601.ch-001 · Cited by 4,382
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Selected major risk factors and global and regional burden of disease
Ezzati, M., Lopez, A. D., Rodgers, A., Vander Hoorn, S., & Murray, C. J. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11403-6 · Cited by 3,594
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591
A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes
Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238
Self-citation
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
Kadowaki, T. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29126 · Cited by 2,824
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D. J., Gratton, J., McCabe, T. J. D., Fontana, J. T., Fujio, Y., Walsh, K. X., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,585
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
Julius, S., Kjeldsen, S. E., Weber, M. A., Brunner, H. R., Ekman, S., Hansson, L., Hua, T. A., Laragh, J. H., McInnes, G. T., Mitchell, L., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16451-9 · Cited by 2,557
The Spread of the Obesity Epidemic in the United States, 1991-1998
Mokdad, A. H. (1999) · JAMA · doi:10.1001/jama.282.16.1519 · Cited by 2,384
AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity
Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,239
Adipose Tissue, Inflammation, and Cardiovascular Disease
Berg, A. H., & Scherer, P. E. (2005) · Circulation Research · doi:10.1161/01.res.0000163635.62927.34 · Cited by 2,113
Self-citation
cDNA Cloning and Expression of a Novel Adipose Specific Collagen-like Factor, apM1 (AdiposeMost Abundant Gene Transcript 1)
Maeda, K., Okubo, K., Shimomura, I., Funahashi, T., Matsuzawa, Y., & Matsubara, K. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.0587 · Cited by 2,081
Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States
Wolf-Maier, K. (2003) · JAMA · doi:10.1001/jama.289.18.2363 · Cited by 1,727
Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions
Yamauchi, T., Nio, Y., Maki, T., Kobayashi, M., Takazawa, T., Iwabu, M., Okada-Iwabu, M., Kawamoto, S., Kubota, N., Kubota, T., et al. (2007) · Nature Medicine · doi:10.1038/nm1557 · Cited by 1,396
Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity
Pajvani, U. B., Hawkins, M., Combs, T. P., Rajala, M. W., Doebber, T., Berger, J. P., Wagner, J. A., Wu, M., Knopps, A., Xiang, A. H., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311113200 · Cited by 1,163
Self-citation
Adipose Tissue
Scherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,092
Self-citation
Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin
Pajvani, U. B., Du, X., Combs, T. P., Berg, A. H., Rajala, M. W., Schulthess, T., Engel, J., Brownlee, M., & Scherer, P. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207198200 · Cited by 1,090
Self-citation
Identification of Telmisartan as a Unique Angiotensin II Receptor Antagonist With Selective PPARγ–Modulating Activity
Benson, S. C., Pershadsingh, H. A., Ho, C. I., Chittiboyina, A. G., Desai, P. V., Pravenec, M., Qi, N., Wang, J., Avery, M. A., & Kurtz, T. W. (2004) · Hypertension · doi:10.1161/01.hyp.0000123072.34629.57 · Cited by 1,076
Dynamic activation of endothelial nitric oxide synthase by Hsp90
García‐Cardeña, G., Fan, R., Shah, V. H., Sorrentino, R., Cirino, G., Papapetropoulos, A., & Sessa, W. C. (1998) · Nature · doi:10.1038/33934 · Cited by 1,029
Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells
Chen, H., Montagnani, M., Funahashi, T., Shimomura, I., & Quon, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307878200 · Cited by 994
The spread of the obesity epidemic in the United States
Mokdad, A. H., Serdula, M. K., & Dietz, W. H. (1999) · Cited by 985
Isolation and Characterization of GBP28, a Novel Gelatin-Binding Protein Purified from Human Plasma
Nakano, Y., Tobe, T., Choi-Miura, N.-H., Mazda, T., & Tomita, M. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021483 · Cited by 915
The Kidney, Hypertension, and Obesity
Hall, J. E. (2003) · Hypertension · doi:10.1161/01.hyp.0000052314.95497.78 · Cited by 868
Body Mass Index and the Prevalence of Hypertension and Dyslipidemia
Brown, C., HIGGINS, M. W., Donato, K. A., Rohde, F. C., Garrison, R. J., Obarzanek, E., Ernst, N. D., & Horan, M. J. (2000) · Obesity Research · doi:10.1038/oby.2000.79 · Cited by 850
Adiponectin Stimulates AMP-Activated Protein Kinase in the Hypothalamus and Increases Food Intake
Kubota, N., Yano, W., Kubota, T., Yamauchi, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Okamoto, S., Shiuchi, T., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.003 · Cited by 844
Role of Superoxide in Angiotensin II–Induced but Not Catecholamine-Induced Hypertension
Laursen, J. B., Rajagopalan, S., Galis, Z. S., Tarpey, M. M., Freeman, B. Α., & Harrison, D. G. (1997) · Circulation · doi:10.1161/01.cir.95.3.588 · Cited by 820
Obesity-Associated Hypertension
Rahmouni, K., Correia, M., Haynes, W. G., & Mark, A. L. (2004) · Hypertension · doi:10.1161/01.hyp.0000151325.83008.b4 · Cited by 788
Induction of Adiponectin, a Fat-Derived Antidiabetic and Antiatherogenic Factor, by Nuclear Receptors
Iwaki, M., Matsuda, M., Maeda, N., Funahashi, T., Matsuzawa, Y., Makishima, M., & Shimomura, I. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1655 · Cited by 747
Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
Schupp, M., Janke, J., Clasen, R., Unger, T., & Kintscher, U. (2004) · Circulation · doi:10.1161/01.cir.0000127955.36250.65 · Cited by 707
APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function
Mao, X., Kikani, C. K., Riojas, R. A., Langlais, P. R., Wang, L., Ramos, F. J., Fang, Q., Christ-Roberts, C. Y., Hong, J., Kim, R. Y., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1404 · Cited by 671
Adiponectin: A Novel Adipokine Linking Adipocytes and Vascular Function
Goldstein, B. J., & Scalia, R. G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0518 · Cited by 647
Hypoadiponectinemia Is an Independent Risk Factor for Hypertension
Iwashima, Y., Katsuya, T., Ishikawa, K., Ouchi, N., Ohishi, M., Sugimoto, K., Fu, Y., Motone, M., Yamamoto, K. I., Matsuo, A., et al. (2004) · Hypertension · doi:10.1161/01.hyp.0000129281.03801.4b · Cited by 609
Association of Hypoadiponectinemia With Impaired Vasoreactivity
Ouchi, N., Ohishi, M., Kihara, S., Funahashi, T., Nakamura, T., Nagaretani, H., Kumada, M., Ohashi, K., Okamoto, Y., Nishizawa, H., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000083488.67550.b8 · Cited by 597
Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPAR Agonists: A Potential Mechanism of Insulin Sensitization
Combs, T. P., Wagner, J. A., Berger, J. P., Doebber, T. W., Wang, W., Zhang, B. B., Tanen, M., Berg, A. H., O’Rahilly, S., Savage, D. B., et al. (2002) · Endocrinology · doi:10.1210/endo.143.3.8662 · Cited by 568
Self-citation
Adiponectin Multimeric Complexes and the Metabolic Syndrome Trait Cluster
Lara‐Castro, C., Luo, N., Wallace, P., Klein, R. L., & Garvey, W. T. (2006) · Diabetes · doi:10.2337/diabetes.55.01.06.db05-1105 · Cited by 480
Blockade of the Renin-Angiotensin System Increases Adiponectin Concentrations in Patients With Essential Hypertension
Furuhashi, M., Ura, N., Higashiura, K., Murakami, H., Tanaka, M., Moniwa, N., Yoshida, D., & Shimamoto, K. (2003) · Hypertension · doi:10.1161/01.hyp.0000078490.59735.6e · Cited by 460
How to assess sympathetic activity in humans
Grassi, G., & Esler, M. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917060-00001 · Cited by 455
THE REGULATION AND PHARMACOLOGY OF ENDOTHELIAL NITRIC OXIDE SYNTHASE
Dudzinski, D. M., Igarashi, J., Greif, D. M., & Michel, T. M. (2005) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121844 · Cited by 424
Adiponectin Replenishment Ameliorates Obesity-Related Hypertension
Ohashi, K., Kihara, S., Ouchi, N., Kumada, M., Fujita, K., Hiuge, A., Hibuse, T., Ryo, M., Nishizawa, H., Maeda, N., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000222368.43759.a1 · Cited by 400
The sympathetic nervous system and the metabolic syndrome
Mancia, G., Bousquet, P., Elghozi, J. L., Esler, M., Grassi, G., Julius, S., Reid, J., & Van Zwieten, P. A. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e328048d004 · Cited by 385
Obesity hypertension: role of leptin and sympathetic nervous system
Hall, J. E. (2001) · American Journal of Hypertension · doi:10.1016/s0895-7061(01)02077-5 · Cited by 361
Hypoadiponectinemia Is Associated with Impaired Endothelium-Dependent Vasodilation
Tan, K. C. B., Xu, A., Chow, W.-S., Lam, M. C., Ai, V. H. G., Tam, S., & Lam, K. S. L. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031012 · Cited by 356
Adiponectin actions in the cardiovascular system
Hopkins, T. A., Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.009 · Cited by 331
Adiponectin-Induced Endothelial Nitric Oxide Synthase Activation and Nitric Oxide Production Are Mediated by APPL1 in Endothelial Cells
Cheng, K. K. Y., Lam, K. S. L., Wang, Y., Huang, Y., Carling, D., Wu, D., Wong, C., & Xu, A. (2007) · Diabetes · doi:10.2337/db06-1580 · Cited by 318
Secretion of the Adipocyte-Specific Secretory Protein Adiponectin Critically Depends on Thiol-Mediated Protein Retention
Wang, Z. V., Schraw, T., Kim, J., Khan, T., Rajala, M. W., Follenzi, A., & Scherer, P. E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00931-06 · Cited by 307
Self-citation
Selective Angiotensin II Receptor Antagonism Reduces Insulin Resistance in Obese Zucker Rats
Henriksen, E. J., Jacob, S., Kinnick, T. R., Teachey, M. K., & Krekler, M. (2001) · Hypertension · doi:10.1161/hy1101.092970 · Cited by 293
Relation of obesity and diet to sympathetic nervous system activity.
Troisi, R. J., Weiss, S. T., Parker, D. R., Sparrow, D., Young, J. B., & Landsberg, L. (1991) · Hypertension · doi:10.1161/01.hyp.17.5.669 · Cited by 267
Adiponectin deficiency increases leukocyte-endothelium interactions via upregulation of endothelial cell adhesion molecules in vivo
Ouedraogo, R., Gong, Y., Berzins, B., Wu, X., Mahadev, K., Hough, K., Chan, L., Goldstein, B. J., & Scalia, R. G. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29623 · Cited by 265
Adiponectin gene expression is inhibited by β‐adrenergic stimulation via protein kinase A in 3T3‐L1 adipocytes
Faßhauer, M., Klein, J. C., Neumann, S., Eszlinger, M., & Paschke, R. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02960-x · Cited by 263
Hypoadiponectinemia as a Predictor for the Development of Hypertension
Chow, W.-S., Cheung, B. M. Y., Tso, A. W. K., Xu, A., Wat, N. M. S., Fong, C. H.-Y., Ong, L. H. Y., Tam, S., Tan, K. C. B., Janus, E. D., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.086835 · Cited by 262
PPARγ-Activating Angiotensin Type-1 Receptor Blockers Induce Adiponectin
Clasen, R., Schupp, M., Foryst‐Ludwig, A., Sprang, C., Clemenz, M., Krikov, M., Thöne‐Reineke, C., Unger, T., & Kintscher, U. (2005) · Hypertension · doi:10.1161/01.hyp.0000168046.19884.6a · Cited by 257
Mechanisms of Early Insulin-Sensitizing Effects of Thiazolidinediones in Type 2 Diabetes
Tonelli, J., Li, W., Kishore, P., Pajvani, U. B., Kwon, E., Weaver, C. L., Scherer, P. E., & Hawkins, M. A. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1621 · Cited by 247
Self-citation
Effects of Weight Loss in Overweight/Obese Individuals and Long-Term Hypertension Outcomes: A Systematic Review
Aucott, L., Poobalan, A., Smith, W. C. S., Avenell, A., Jung, R., & Broom, J. (2005) · Hypertension · doi:10.1161/01.hyp.0000165680.59733.d4 · Cited by 241
Adiponectin complexes in human cerebrospinal fluid: distinct complex distribution from serum
Kusminski, C. M., McTernan, P. G., Schraw, T., Kos, K., O’Hare, J. P., Ahima, R. S., Kumar, S., & Scherer, P. E. (2007) · Diabetologia · doi:10.1007/s00125-006-0577-9 · Cited by 225
Self-citation
Globular adiponectin upregulates nitric oxide production in vascular endothelial cells
Hattori, Y., Suzuki, M., Hattori, S., & Kasai, K. (2003) · Diabetologia · doi:10.1007/s00125-003-1224-3 · Cited by 210
Transcriptional and posttranscriptional regulation of endothelial nitric oxide synthase expression
Searles, C. D. (2006) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00457.2005 · Cited by 208
Brain Adipocytokine Action and Metabolic Regulation
Ahima, R. S., Qi, Y., Singhal, N. S., Jackson, M. B., & Scherer, P. E. (2006) · Diabetes · doi:10.2337/db06-s018 · Cited by 150
Self-citation
The Renin-Angiotensin System and Its Receptors
Stroth, U., & Unger, T. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199900001-00005 · Cited by 146
Angiotensin II infusion decreases plasma adiponectin level via its type 1 receptor in rats: an implication for hypertension-related insulin resistance
Ran, J., Hirano, T., Fukui, T., Saito, K., Kageyama, H., Okada, K., & Adachi, M. (2006) · Metabolism · doi:10.1016/j.metabol.2005.10.009 · Cited by 140
Molecular activation of PPARγ by angiotensin II type 1-receptor antagonists
Erbe, D. V., Gartrell, K., Zhang, Y., Suri, V., Kirincich, S. J., Will, S., Perreault, M., Wang, S., & Tobin, J. F. (2006) · Vascular Pharmacology · doi:10.1016/j.vph.2006.05.002 · Cited by 135
Sympathetic Overdrive and Cardiovascular Risk in the Metabolic Syndrome
Grassi, G. M. (2006) · Hypertension Research · doi:10.1291/hypres.29.839 · Cited by 131
Stimulated HSP90 binding to eNOS and activation of the PI3–Akt pathway contribute to globular adiponectin-induced NO production: Vasorelaxation in response to globular adiponectin
Wang, X., Satoh, H., Kase, H., Suzuki, K., & Hattori, Y. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.111 · Cited by 116
Effect of antihypertensive agents on plasma adiponectin levels in hypertensive patients with metabolic syndrome
Yılmaz, M. İ., Sönmez, A., Çağlar, K., Celık, T., Yenicesu, M., Eyileten, T., Açıkel, C., Oğuz, Y., Yavuz, İ., & Vural, A. (2007) · Nephrology · doi:10.1111/j.1440-1797.2007.00764.x · Cited by 112
Effects of adiponectin on the renal sympathetic nerve activity and blood pressure in rats.
Tanida, M., Shen, J., Horii, Y., Matsuda, M., Kihara, S., Funahashi, T., Shimomura, I., Sawai, H., Fukuda, Y., Matsuzawa, Y., et al. (2007) · PubMed · Cited by 95
Cold Exposure Suppresses Serum Adiponectin Levels through Sympathetic Nerve Activation in Mice
Imai, J., Katagiri, H., Yamada, T., Ishigaki, Y., Ogihara, T., Uno, K., Hasegawa, Y., Gao, J., Ishihara, H., Sasano, H., et al. (2006) · Obesity · doi:10.1038/oby.2006.130 · Cited by 91
Blockade of Sympathetic Nervous System Activity by Rilmenidine Increases Plasma Adiponectin Concentration in Patients With Essential Hypertension
Nowak, Ł., Adamczak, M., & Wiecek, A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.026 · Cited by 59
Rosiglitazone — Continued Uncertainty about Safety
Drazen, J. M., Morrissey, S., & Curfman, G. (2007) · New England Journal of Medicine · doi:10.1056/nejme078118 · Cited by 56
The effect of losartan and amlodipine on serum adiponectin in Japanese adults with essential hypertension
Watanabe, S., Okura, T., Kurata, M., Irita, J., Manabe, S., Miyoshi, K., Fukuoka, T., Murakami, K., & Higaki, J. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.10.012 · Cited by 49
Vascular protection in diabetes: a pharmacological view of angiotensin II type 1 receptor blockers
Kintscher, U., & Unger, T. (2005) · Acta Diabetologica · doi:10.1007/s00592-005-0178-y · Cited by 34
World Hypertension Day 2007
Jones, D. W., & Hall, J. E. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.088740 · Cited by 34
World Hypertension Day
Smith, E. R. (2006) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(06)70274-4 · Cited by 16

Flagged first, then by citations

Research works printed but not linked: 3

10.1016/S0140-6736(05)70151-3 · DOI
10.1161/hyp.38.4.884 · DOI
10.1161/circ.95.3.588 · DOI

Sorted by citations

Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
Maury, E., & Brichard, S. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.031 · Cited by 1,026
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Endothelial dysfunction and vascular disease
Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Félétou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 824
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
Self-citation
Adiponectin regulation and function
Fang, H., & Judd, R. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170046 · Cited by 631
Local Inflammation and Hypoxia Abolish the Protective Anticontractile Properties of Perivascular Fat in Obese Patients
Greenstein, A. S., Khavandi, K., Withers, S., Sonoyama, K., Clancy, O., Jeziorska, M., Laing, I., Yates, A. P., Pemberton, P. W., Malik, R. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.821181 · Cited by 616
Adiponectin, the past two decades
Wang, Z. V., & Scherer, P. E. (2016) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjw011 · Cited by 609
Self-citation
The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases
Balistreri, C. R., Caruso, C., & Candore, G. (2010) · Mediators of Inflammation · doi:10.1155/2010/802078 · Cited by 576
Thirty Years of Saying NO
Vanhoutte, P. M., Zhao, Y., Xu, A., & Leung, S. W. S. (2016) · Circulation Research · doi:10.1161/circresaha.116.306531 · Cited by 406
Adiponectin action from head to toe
Brochu‐Gaudreau, K., Rehfeldt, C., Blouin, R., Bordignon, V., Murphy, B. D., & Palin, M. (2009) · Endocrine · doi:10.1007/s12020-009-9278-8 · Cited by 330
Diabetes and apoptosis: lipotoxicity
Kusminski, C. M., Shetty, S., Orci, L., Unger, R. H., & Scherer, P. E. (2009) · Apoptosis · doi:10.1007/s10495-009-0352-8 · Cited by 302
Self-citation
CTRP family: linking immunity to metabolism
Schäffler, A., & Buechler, C. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.12.003 · Cited by 305
Adiponectin and cardiovascular health: an update
Hui, X. H., Lam, K. S., Vanhoutte, P. M., & Xu, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01395.x · Cited by 295
Metabolically-Healthy Obesity and Coronary Artery Calcification
Chang, Y., Kim, B.-K., Yun, K. E., Cho, J., Zhang, Y., Rampal, S., Zhao, D., Jung, H. S., Choi, Y., Ahn, J., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2014.03.042 · Cited by 269
Endothelial Nitric Oxide Synthase Uncoupling and Perivascular Adipose Oxidative Stress and Inflammation Contribute to Vascular Dysfunction in a Rodent Model of Metabolic Syndrome
Marchesi, C., Ebrahimian, T., Angulo, O. J., Paradis, P., & Schiffrin, E. L. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.138305 · Cited by 262
Adiponectin, Obesity, and Cancer: Clash of the Bigwigs in Health and Disease
Parida, S., Siddharth, S., & Sharma, D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102519 · Cited by 248
Mechanisms linking obesity to hypertension
Dorresteijn, J. A. N., Visseren, F. L. J., & Spiering, W. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2011.00914.x · Cited by 218
The Control of Food Intake: Behavioral versus Molecular Perspectives
Woods, S. C. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.04.007 · Cited by 204
Adiponectin Promotes Functional Recovery after Podocyte Ablation
Rutkowski, J. M., Wang, Z. V., Park, A. S. D., Zhang, J., Zhang, D., Hu, M. C., Moe, O. W., Suszták, K., & Scherer, P. E. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012040414 · Cited by 169
Self-citation
Adipose Organ Development and Remodeling
Cinti, S. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170042 · Cited by 197
Free radicals and male reproduction.
Agarwal, A. K., & Allamaneni, S. S. R. (2011) · PubMed · Cited by 154
Adiponectin Levels and the Risk of Hypertension
Kim, D. H., Kim, C., Ding, E. L., Townsend, M. K., & Lipsitz, L. A. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01453 · Cited by 165
The role of the sympathetic nervous system in obesity-related hypertension
da Silva, A. A., do Carmo, J. M., Dubinion, J. H., & Hall, J. E. (2009) · Current Hypertension Reports · doi:10.1007/s11906-009-0036-3 · Cited by 156
Cross-talk between adipose tissue and vasculature: role of adiponectin
Li, F. Y. L., Cheng, K. K. Y., Lam, K. S. L., Vanhoutte, P. M., & Xu, A. (2010) · Acta Physiologica · doi:10.1111/j.1748-1716.2010.02216.x · Cited by 155
Epoxyeicosatrienoic Acid Agonist Rescues the Metabolic Syndrome Phenotype of HO-2-Null Mice
Sodhi, K., Inoue, K., Gotlinger, K. H., Canestraro, M., Vanella, L., Kim, D., Manthati, V. L., Koduru, S. R., Falck, J. R., Schwartzman, M. L., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.157545 · Cited by 143
HO-1 overexpression and underexpression: Clinical implications
Drummond, G. S., Baum, J., Greenberg, M., Lewis, D., & Abraham, N. G. (2019) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2019.108073 · Cited by 142
Diabetic cardiomyopathy: mechanisms and therapeutic targets
Battiprolu, P. K., Gillette, T. G., Wang, Z. V., Lavandero, S., & Hill, J. A. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.08.001 · Cited by 144
Self-citation
Adiponectin as a potential biomarker of vascular disease
Mohammadi, S., Arefhosseini, S. R., Ebrahimi‐Mameghani, M., Fallah, P., & Bazi, Z. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s48753 · Cited by 129
Translational Significance of Heme Oxygenase in Obesity and Metabolic Syndrome
Abraham, N. G., Junge, J. M., & Drummond, G. S. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.09.003 · Cited by 126
Non-alcoholic fatty liver disease is associated with left ventricular diastolic dysfunction in essential hypertension
Fallo, F., Pozza, A. D., Sonino, N., Lupia, M., Tona, F., Federspil, G., Ermani, M., Catena, C., Soardo, G., Piazza, L. D., et al. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2008.12.007 · Cited by 114
Role of adiponectin system in insulin resistance
Caselli, C. (2014) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2014.09.003 · Cited by 111
Central adiposity associations to carbohydrate and lipid metabolism in individuals with complete motor spinal cord injury
Gorgey, A. S., Mather, K. J., & Gater, D. R. (2010) · Metabolism · doi:10.1016/j.metabol.2010.08.002 · Cited by 109
Endothelial dysfunction in cirrhosis: Role of inflammation and oxidative stress
Vairappan, B. (2015) · World Journal of Hepatology · doi:10.4254/wjh.v7.i3.443 · Cited by 107
Heme oxygenase: the key to renal function regulation
Abraham, N. G., Cao, J. J., Sacerdoti, D., Li, X., & Drummond, G. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90449.2008 · Cited by 102
The Role of Adiponectin in Endothelial Dysfunction and Hypertension
Rojas, E., Rodríguez-Molina, D., Bolli, P., Israili, Z. H., Faría, J., Fidilio, E., Bermúdez, V., & Velasco, M. (2014) · Current Hypertension Reports · doi:10.1007/s11906-014-0463-7 · Cited by 104
Eosinophils are key regulators of perivascular adipose tissue and vascular functionality
Withers, S., Forman, R. A., Meza‐Perez, S., Sorobetea, D., Sitnik, K., Hopwood, T. W., Lawrence, C. B., Agace, W. W., Else, K. J., Heagerty, A. M., et al. (2017) · Scientific Reports · doi:10.1038/srep44571 · Cited by 101
Adiponectin Action: A Combination of Endocrine and Autocrine/Paracrine Effects
Dadson, K., Liu, Y., & Sweeney, G. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00062 · Cited by 100
Leptin, Not Adiponectin, Predicts Hypertension in the Copenhagen City Heart Study
Asferg, C. L., Møgelvang, R., Flyvbjerg, A., Frystyk, J., Jensen, J. S., Marott, J. L., Appleyard, M., Jensen, G., & Jeppesen, J. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.244 · Cited by 96
Heme Oxygenase Gene Targeting to Adipocytes Attenuates Adiposity and Vascular Dysfunction in Mice Fed a High-Fat Diet
Cao, J., Peterson, S. J., Sodhi, K., Vanella, L., Barbagallo, I., Rodella, L. F., Schwartzman, M. L., Abraham, N. G., & Kappas, A. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.193805 · Cited by 94
Modulation of glycosphingolipid metabolism significantly improves hepatic insulin sensitivity and reverses hepatic steatosis in mice #
Bijl, N., Sokolović, M., Vrins, C. L. J., Langeveld, M., Moerland, P. D., Ottenhoff, R., van Roomen, C. P. A. A., Claessen, N., Boot, R. G., Aten, J., et al. (2009) · Hepatology · doi:10.1002/hep.23175 · Cited by 94
Diabetic cardiomyopathy and metabolic remodeling of the heart
Battiprolu, P. K., Lopez-Crisosto, C., Wang, Z. V., Nemchenko, A., Lavandero, S., & Hill, J. A. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.10.011 · Cited by 91
Self-citation
Plasma total and high molecular weight adiponectin levels and risk of coronary heart disease in women
Pischon, T., Hu, F. B., Girman, C. J., Rifai, N., Manson, J. E., Rexrode, K. M., & Rimm, E. B. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.07.011 · Cited by 91
Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome
Chedraui, P. A., Pérez-López, F. R., Escobar, G. S., Palla, G., Guevara, M. M. M., Cecchi, E., Genazzani, A. R., & Simoncini, T. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.06.008 · Cited by 91
Serum concentrations of adiponectin, leptin, resistin, ghrelin and insulin and their association with obesity indices in obese normo- and hypertensive patients – pilot study
Stȩpień, M., Wlazeł, R. N., Paradowski, M. T., Banach, M., Rysz-Górzyńska, M., Misztal, M., & Rysz, J. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.29518 · Cited by 81
Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges
Lei, X., Qiu, S., Yang, G., & Wu, Q. (2022) · Genes & Diseases · doi:10.1016/j.gendis.2022.10.018 · Cited by 91
Targeting Heme Oxygenase
Peterson, S. J., & Frishman, W. H. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e31819d813a · Cited by 79
Obesity and Insulin Resistance in Resistant Hypertension: Implications for the Kidney
Rao, A., Pandya, V., & Whaley‐Connell, A. T. (2015) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2014.12.004 · Cited by 78
Recombinant CTRP9 administration attenuates neuroinflammation via activating adiponectin receptor 1 after intracerebral hemorrhage in mice
Zhao, L., Chen, S., Sherchan, P., Ding, Y. P., Zhao, W., Guo, Z., Yu, J., Tang, J., & Zhang, J. H. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1256-8 · Cited by 73
A Soluble Activin Receptor Type IIB Prevents the Effects of Androgen Deprivation on Body Composition and Bone Health
Koncarevic, A., Cornwall-Brady, M., Pullen, A., Davies, M., Sako, D., Liu, J., Kumar, R., Tomkinson, K., Baker, T., Umiker, B., et al. (2010) · Endocrinology · doi:10.1210/en.2010-0134 · Cited by 71
Physiological role of adiponectin in different tissues: a review
Esmaili, S., Hemmati, M., & Karamian, M. (2018) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2018.1493606 · Cited by 73
The adipose tissue production of adiponectin is increased in end-stage renal disease
Cantarin, M. P. M., Waldman, S. A., Doria, C., Frank, A. M., Maley, W. R., Ramirez, C. B., Keith, S. W., & Falkner, B. E. (2013) · Kidney International · doi:10.1038/ki.2012.421 · Cited by 71
Roles of leptin, adiponectin and resistin in the transcriptional regulation of steroidogenic genes contributing to decreased Leydig cells function in obesity
Roumaud, P., & Martin, L. J. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0046 · Cited by 70
Adiponectin: friend or foe in obesity and inflammation
Luo, L., & Liu, M. (2022) · Medical Review · doi:10.1515/mr-2022-0002 · Cited by 71
Regional Fat Distribution and Blood Pressure Level and Variability
Yano, Y., Vongpatanasin, W., Ayers, C. R., Turer, A. T., Chandra, A., Carnethon, M. R., Greenland, P., de Lemos, J. A., & Neeland, I. J. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07876 · Cited by 67
Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability
Li, B., Po, S. S., Zhang, B., Bai, F., Li, J., Qin, F., Liu, N., Sun, C., Xiao, Y., Tu, T., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15407 · Cited by 63
Role of Adipokines in Atherosclerosis: Interferences with Cardiovascular Complications in Rheumatic Diseases
Scotece, M., Conde, J., Gómez, R., López, V., Pino, J., Gonzalez, A., Lago, F., Gómez-Reino, J. J., & Gualillo, O. (2012) · Mediators of Inflammation · doi:10.1155/2012/125458 · Cited by 63
Targeting perivascular and epicardial adipose tissue inflammation: therapeutic opportunities for cardiovascular disease
Rafeh, R. W., Viveiros, A., Oudit, G. Y., & EL‐Yazbi, A. F. (2020) · Clinical Science · doi:10.1042/cs20190227 · Cited by 63
Assessment of Endothelial Dysfunction in Childhood Obesity and Clinical Use
Bruyndonckx, L., Hoymans, V. Y., Craenenbroeck, A. H. V., Vissers, D. K., Vrints, C. J., Ramet, J., & Conraads, V. M. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/174782 · Cited by 66
Association of Japanese dietary pattern with serum adiponectin concentration in Japanese adult men
Guo, H., Niu, K., Monma, H., Kobayashi, Y., Guan, L., Sato, M., Minamishima, D., & Nagatomi, R. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.06.006 · Cited by 61
Back to the heart: The protective role of adiponectin
Caselli, C., D’Amico, A., Cabiati, M., Prescimone, T., Ry, S. D., & Giannessi, D. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.03.003 · Cited by 61
Implications of adiponectin in linking metabolism to testicular function
Martin, L. J. (2013) · Endocrine · doi:10.1007/s12020-013-0102-0 · Cited by 60
Neuroprotective effect of osmotin against ethanol-induced apoptotic neurodegeneration in the developing rat brain
Naseer, M. I., Ullah, I., Narasimhan, M. L., Lee, H. Y., Bressan, R. A., Yoon, G. H., Yun, D., & Kim, M. O. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.53 · Cited by 59
EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels
Sodhi, K., Puri, N., Inoue, K., Falck, J. R., Schwartzman, M. L., & Abraham, N. G. (2011) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2011.12.004 · Cited by 57
Biomarkers of dysfunctional visceral fat
Gugliucci, A. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2022.03.001 · Cited by 59
Involvement of adiponectin in the pathogenesis of dystrophinopathy
Abou-Samra, M., Lecompte, S., Schakman, O., Noel, L., Many, M. C., Gailly, P., & Brichard, S. M. (2015) · Skeletal Muscle · doi:10.1186/s13395-015-0051-9 · Cited by 55
Autonomic nerves and perivascular fat: Interactive mechanisms
Bulloch, J. M., & Daly, C. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.005 · Cited by 52
Multiple Adipose Depots Increase Cardiovascular Risk via Local and Systemic Effects
Karastergiou, K., & Fried, S. K. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0361-5 · Cited by 55
Once fat was fat and that was that : our changing perspectives on adipose tissue
Ferris, W. F., & Crowther, N. J. (2011) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2010-083 · Cited by 56
Adiponectin confers protection from acute colitis and restricts a B cell immune response
Obeid, S., Wankell, M., Charrez, B., Sternberg, J., Kreuter, R., Esmaili, S., Ramezani–Moghadam, M., Devine, C., Read, S. A., Bhathal, P. S., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712646 · Cited by 51
The role of adiponectin in cardiovascular disease
Peng, J., Chen, Q., & Wu, C. (2023) · Cardiovascular Pathology · doi:10.1016/j.carpath.2022.107514 · Cited by 56
Oxidized low-density lipoprotein, angiotensin II and increased waist cirumference are associated with valve inflammation in prehypertensive patients with aortic stenosis
Côté, N., Pîbarot, P., Pépin, A., Fournier, D., Audet, A., Arsenault, B. J., Couture, C., Poirier, P., Després, J., & Mathieu, P. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.05.054 · Cited by 50
Physiological significance of heme oxygenase in hypertension
Cao, J. J., Inoue, K., Li, X., Drummond, G., & Abraham, N. G. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.10.025 · Cited by 49
Agonists of epoxyeicosatrienoic acids reduce infarct size and ameliorate cardiac dysfunction via activation of HO-1 and Wnt1 canonical pathway
Cao, J. J., Tsenovoy, P. L., Thompson, E. A., Falck, J. R., Touchon, R. C., Sodhi, K., Rezzani, R., Shapiro, J. I., & Abraham, N. G. (2015) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2015.01.002 · Cited by 49
Increased Levels of Systolic Blood Pressure Within the Normal Range Are Associated With Significantly Elevated Risks of Nonalcoholic Fatty Liver Disease
Wu, S., Zou, H., Zhu, G., Wang, L., Zhang, Q., Shi, K., Han, J., Huang, W., Braddock, M., Chen, Y., et al. (2015) · Medicine · doi:10.1097/md.0000000000000842 · Cited by 46
Sex differences in obesity-induced hypertension and vascular dysfunction: a protective role for estrogen in adipose tissue inflammation?
Taylor, L. E., & Sullivan, J. C. (2016) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00202.2016 · Cited by 47
Adipokines: Novel Players in Resistant Hypertension
de Faria, A. P., Modolo, R., Fontana, V., & Moreno, H. (2014) · Journal of Clinical Hypertension · doi:10.1111/jch.12399 · Cited by 44
The role of adiponectin in placentation and preeclampsia
Adu‐Gyamfi, E. A., Fondjo, L. A., Owiredu, W. K. B. A., Czika, A., Nelson, W., Lamptey, J., Wang, Y., & Ding, Y. (2019) · Cell Biochemistry and Function · doi:10.1002/cbf.3458 · Cited by 44
Obesity
Sušić, D., & Varagić, J. (2016) · Medical Clinics of North America · doi:10.1016/j.mcna.2016.08.008 · Cited by 45
Increased Muscle Mass Protects Against Hypertension and Renal Injury in Obesity
Butcher, J. T., Mintz, J. D., Larion, S., Qiu, S., Ruan, L., Fulton, D. J., & Stepp, D. W. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009358 · Cited by 41
Adiponectin acts in the nucleus of the solitary tract to decrease blood pressure by modulating the excitability of neuropeptide Y neurons
Hoyda, T. D., Smith, P., & Ferguson, A. V. (2008) · Brain Research · doi:10.1016/j.brainres.2008.12.012 · Cited by 40
Nonalcoholic fatty liver disease, adiponectin and insulin resistance in dipper and nondipper essential hypertensive patients
Fallo, F., Pozza, A. D., Sonino, N., Federspil, G., Ermani, M., Baroselli, S., Catena, C., Soardo, G., Carretta, R., Belgrado, D., et al. (2008) · Journal of Hypertension · doi:10.1097/hjh.0b013e32830dfe4b · Cited by 42
Preventive effect of Eucommia leaf extract on aortic media hypertrophy in Wistar-Kyoto rats fed a high-fat diet
Hosoo, S., Koyama, M., Watanabe, A., Ishida, R., Hirata, T., Yamaguchi, Y., Yamasaki, H., Wada, K., Higashi, Y., & Nakamura, K. (2017) · Hypertension Research · doi:10.1038/hr.2016.189 · Cited by 42
Aortic dysfunction in metabolic syndrome mediated by perivascular adipose tissue TNFα‐ and NOX2‐dependent pathway
DeVallance, E., Branyan, K., Lemaster, K., Olfert, I. M., Smith, D. M., Pistilli, E. E., Frisbee, J. C., & Chantler, P. D. (2018) · Experimental Physiology · doi:10.1113/ep086818 · Cited by 41
Exercise training prevents the perivascular adipose tissue-induced aortic dysfunction with metabolic syndrome
DeVallance, E., Branyan, K., Lemaster, K. C., Anderson, R., Marshall, K. L., Olfert, I., Smith, D. M., Kelley, E. E., Bryner, R., Frisbee, J., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101285 · Cited by 35
Effects of resistance exercise on adipokine factors and body composition in pre- and postmenopausal women
Park, K. M., Park, S. C., & Kang, S. (2019) · Journal of Exercise Rehabilitation · doi:10.12965/jer.1938368.184 · Cited by 45
Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome
Henneman, P., Janssens, A. C. J. W., Zillikens, M. C., Frölich, M. A., Frants, R. R., Oostra, B. A., van Duijn, C. M., & van Dijk, K. W. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02162.x · Cited by 40
Enhanced Fatty Acid Flux Triggered by Adiponectin Overexpression
Shetty, S., Ramos-Román, M. A., Cho, Y.-R., Brown, J. D., Plutzky, J., Muise, E. S., Horton, J. D., Scherer, P. E., & Parks, E. J. (2011) · Endocrinology · doi:10.1210/en.2011-1339 · Cited by 38
Self-citation
Oxidized HDL, Adipokines, and Endothelial Dysfunction: A Potential Biomarker Profile for Cardiovascular Risk in Women with Obesity
Peterson, S. J., Shapiro, J. I., Thompson, E. A., Singh, S. P., Liu, L., Weingarten, J. A., O'Hanlon, K. M., Bialczak, A., Bhesania, S., & Abraham, N. G. (2018) · Obesity · doi:10.1002/oby.22354 · Cited by 38
Sex difference in cardiometabolic risk profile and adiponectin expression in subjects with visceral fat obesity
He, H., Ni, Y., Chen, J., Zhao, Z., Zhong, J., Liu, D., Yan, Z., Zhang, W., & Zhu, Z. (2009) · Translational research · doi:10.1016/j.trsl.2009.08.003 · Cited by 37
Adiponectin induces interleukin‐6 production and activates STAT3 in adult mouse cardiac fibroblasts
Liao, W., Yu, C., Wen, J., Jia, W. W.-G., Geng, L., Ke, Y.-N., Zhao, S., & Campell, W. B. (2008) · Biology of the Cell · doi:10.1042/bc20080117 · Cited by 37
Improved myocardial perfusion in chronic diabetic mice by the up‐regulation of pLKB1 and AMPK signaling
Kusmic, C., L’Abbate, A., Sambuceti, G., Drummond, G., Barsanti, C., Matteucci, M., Cao, J. J., Piccolomini, F., Cheng, J., & Abraham, N. G. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22486 · Cited by 38
Heme Oxygenase-1 Upregulation: A Novel Approach in the Treatment of Cardiovascular Disease
Bellner, L., Lebovics, N., Rubinstein, R., Buchen, Y. D., Sinatra, E., Sinatra, G., Abraham, N. G., McClung, J. A., & Thompson, E. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7970 · Cited by 36
Hypertension, Obesity, and Inflammation: The Complex Designs of a Deadly Trio
Rizvi, A. A. (2010) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0116 · Cited by 36
Combination treatment of adipose-derived stem cells and adiponectin attenuates pulmonary arterial hypertension in rats by inhibiting pulmonary arterial smooth muscle cell proliferation and regulating the AMPK/BMP/Smad pathway
Luo, L., Zheng, W., Lian, G., Chen, H., Li, L., Xu, C., & Xie, L. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3226 · Cited by 34
Assembly of adiponectin oligomers
Tsao, T. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9256-6 · Cited by 35
Factors Associated With Cognitive Improvement After Bariatric Surgery Among Patients With Severe Obesity in the Netherlands
Vreeken, D., Seidel, F., Custers, E., Olsthoorn, L., Cools, S., Aarts, E. O., Kleemann, R., Kessels, R. P. C., Wiesmann, M., Hazebroek, E. J., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.15936 · Cited by 33
Adipose proteome analysis: focus on mediators of insulin resistance
Chen, X., & Hess, S. Y. (2008) · Expert Review of Proteomics · doi:10.1586/14789450.5.6.827 · Cited by 33
Mechanisms of Adverse Cardiometabolic Consequences of Obesity
Diaz-Melean, C. M., Somers, V. K., Rodríguez-Escudero, J. P., Singh, P., Sochor, O., Llano, E. M., & López-Jiménez, F. A. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0364-2 · Cited by 37
Adiponectin protects against incident hypertension independent of body fat distribution: observations from the Dallas Heart Study
Peri-Okonny, P., Ayers, C. R., Maalouf, N. M., Das, S. R., de Lemos, J. A., Berry, J. D., Turer, A. T., Neeland, I. J., Scherer, P. E., & Vongpatanasin, W. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2840 · Cited by 33
Self-citation
Ablation of adipose-HO-1 expression increases white fat over beige fat through inhibition of mitochondrial fusion and of PGC1α in female mice
Singh, S. P., Grant, I., Meissner, A., Kappas, A., & Abraham, N. G. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0027 · Cited by 31

Authors: Wang, Z. V., & Scherer, P. E.
Affiliations: Albert Einstein College of Medicine (US)
ORCID: Wang, Zhao V.
Scherer, Philipp E.
Venue: Hypertension
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2008-01
Volume: 51
Issue: 1
Pages: 8-14
ISSN: 0194-911X (ISSN-L)
1524-4563
DOI: 10.1161/hypertensionaha.107.099424
OpenAlex: W2113343244
Cited by: 247
References: 77
Citations by year: 2026: 2 · 2025: 5 · 2024: 7 · 2023: 8 · 2022: 10 · 2021: 9 · 2020: 7 · 2019: 13 · 2018: 14 · 2017: 14 · 2016: 12 · 2015: 21 · 2014: 19 · 2013: 17 · 2012: 16
FWCI: 2.35
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Hypertension (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Cancer Institute (R01CA112023)
National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK 55758, R01DK055758, R24DK071030, R21DK075887, R24-DK071030-01)
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
Keywords: adiponectin, cardiovascular function, adipokines, cardiovascular risk
MeSH terms: Animals, Cardiovascular Diseases, Cardiovascular System, Endothelium, Vascular, Humans, Hypertension, Obesity, Renin-Angiotensin System, Mice, Adiponectin

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Adiponectin, Cardiovascular Function, and Hypertension

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks